• OPEN AN ACCOUNT
Indian Indices
Sensex
81,911.01 31.61
( 0.04%)
Global Indices
Nasdaq
52,502.29 249.40
(0.48%)
Dow Jones
7,647.48 105.55
(1.40%)
Hang Seng
60,763.20 -485.39
(-0.79%)
Nikkei 225
10,863.06 27.59
(0.25%)
Forex
USD-INR
93.57 -0.21
(-0.22%)
EUR-INR
104.78 -0.12
(-0.12%)
GBP-INR
125.37 -0.34
(-0.27%)
JPY-INR
0.59 0.00
(-0.40%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
676.0910732
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
87.33
300380.35
EPS(TTM)
Face Value()
Div & Yield %
129.57
2
0.26
 

setco automotive ltd
Market trade in positive territory; pharma shares rally for 5th day
Nov 08,2026
The equity benchmarks continued to trade in positive terrain during the special Mahurat trading session, buoyed by festive optimism and supportive global and domestic cues. The Nifty traded above the 25,000 level. Pharma shares advanced for the fourth consecutive trading session.

At 15.10 PM IST, the barometer index, the S&P BSE Sensex jumped 199.88 points or 0.25% to 81,227.90. The Nifty 50 index rose 6.35 points or 0.03% to 25,036.60.

The broader market outperformed the frontline indices. The BSE 150 MidCap Index gained 0.42% and the BSE 250 SmallCap Index added 1.39%.

The market breadth was strong. On the BSE, 3,161 shares rose and 798 shares fell. A total of 215 shares were unchanged.

Buzzing Index:

The Nifty Pharma index jumped 1.47% to 28,402.90. The index jumped 4.79% in the four consecutive trading sessions.

Divis Laboratories (up 5.11%), Piramal Pharma (up 2.85%), Sun Pharmaceutical Industries (up 2.6%), Wockhardt (up 2.32%) and Abbott India (up 0.93%) were the top gainers. Among the other gainers were Laurus Labs (up 0.79%), Ajanta Pharma (up 0.49%), Torrent Pharmaceuticals (up 0.49%), Biocon (up 0.44%) and Zydus Lifesciences (up 0.43%).

Stocks in Spotlight:

Tega Industries advanced 1.67%. The company reported a consolidated net loss of Rs 47.4 crore in Q2 FY27 as against a net profit of Rs 44.94 crore posted in Q2 FY26. The company's revenue from operations surged to Rs 4,254.04 crore in Q2 FY27 from Rs 405.35 crore in Q2 FY26.

Finolex Cables surged 19.21% after reporting strong Q2 FY27 results, with consolidated net profit rising 67.8% YoY to Rs 272.92 crore from Rs 162.64 crore in Q2 FY26. On a sequential basis, net profit increased 9.6% from Rs 249.04 crore in Q1 FY27. Revenue from operations rose 65.0% YoY to Rs 2,269.33 crore from Rs 1,375.79 crore. Sequentially, revenue increased 12.7% from Rs 2,013.15 crore.